Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in CareDx, Inc with Losses of $100,000 to Contact the Firm

CDNA

Los Angeles, California--(Newsfile Corp. - June 20, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CareDx, Inc ("CareDx" or "the Company") (NASDAQ: CDNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 24, 2021 and May 5, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before July 22, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. CareDx engaged in improper schemes to inflate both testing service demand and revenue including the use of misleading marketing materials, improper kickbacks to physicians, and bundling testing as part of the RemoTraC service. The Company's schemes left it at greater risk of regulatory scrutiny. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about CareDx, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

SOURCE:
The Schall Law Firm

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/128317



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today